Senator Rick Scott has introduced two new bills aimed at increasing oversight of Chinese companies operating in the United States. The proposed legislation, known as the Chinese List Entity Alignment and Review (CLEAR) Act and the National Defense Supply Chain Integrity Act, is intended to address gaps that have allowed some Chinese military-linked firms to avoid U.S. restrictions.
The CLEAR Act would require the Department of War to review any Chinese entity listed under other U.S. government restrictions and determine whether it should also be included on the 1260H list—a roster of companies identified as benefiting China’s military. The National Defense Supply Chain Integrity Act would limit these companies’ ability to contest their placement on this list.
According to Senator Scott, these measures build on his ongoing efforts to protect national security by tightening rules around federal procurement from Chinese firms and pushing for more comprehensive disclosure of pharmaceutical supply chains.
Senator Scott stated, “For decades, inefficiencies by the United States government have allowed dangerous Communist Chinese companies to continue operating and selling products to our military and American families while benefitting our adversary. If a foreign company is identified as a threat to one aspect of our nation, it should be treated as a threat everywhere. My two bills, the CLEAR Act and National Defense Supply Chain Integrity Act, would streamline the ban of dangerous companies that are included on the Department of War’s 1260H list, the FCC’s Covered List, and any government blacklist to ensure our nation is protected on all fronts and that these companies stay on as long as they are connected to the CCP. These bills will be a great step to closing loopholes in our supply chain that China has exploited for years while providing more tools for President Trump and his administration to safeguard our national security.”
Scott has previously advocated for similar initiatives targeting Chinese influence in critical sectors such as telecommunications and pharmaceuticals.
